SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-113799
Filing Date
2021-09-08
Accepted
2021-09-08 16:12:08
Documents
14
Period of Report
2021-09-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2127087d1_8k.htm   iXBRL 8-K 68794
2 EXHIBIT 99.1 tm2127087d1_ex99-1.htm EX-99.1 57469
6 GRAPHIC tm2127087d1_ex99-1img001.jpg GRAPHIC 14506
  Complete submission text file 0001104659-21-113799.txt   341298

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sbbp-20210809.xsd EX-101.SCH 3209
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbbp-20210809_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbbp-20210809_pre.xml EX-101.PRE 22726
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2127087d1_8k_htm.xml XML 3614
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 8-K | Act: 34 | File No.: 001-37569 | Film No.: 211242267
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences